Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Epidemiology of Leprosy in Childhood: A Retrospective Study

Rusmawardiana R, Fifa Argentina , Indri Widya Sari . Fakultas Kedokteran Universitas Sriwijaya. Bioscientia Medicina : Journal of Biomedicine and Translational Research. 2021; 5 (3) : 508-516.
Download PDF
Publication

Evaluation of the therapeutic management of leprosy in primary care: demand case series referred to a University Hospital in the Midwest region of Brazil

de Sousa P, Sousa ALMD, Turchi MD. Elsevier BV. Anais Brasileiros de Dermatologia. 2021;
Download PDF
Publication

Mental wellbeing among people affected by leprosy in the Terai region, Nepal

van Netten WJ, van Dorst M, Waltz M, et al. Lepra. Leprosy Review. 2021; 92 (1) : 59-74.
Download PDF
Publication

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

Yuan S, Yin X, Meng X, et al. Springer Science and Business Media LLC. Nature. 2021;
Download PDF
Publication

Knowledge and Attitude among Under-Graduate Medical Students towards Leprosy in Tertiary Care Hospital- a Questionnaire Based Study.

Rajegowda HM, Kalegowda D, Madegowda SKB, et al. Journal of Pakistan Association of Dermatologists. 2021; 31 (1) : 69-73.
Download PDF
Publication

Quality of Life in Leprosy Patient with Neuropathic Pain in Donorojo Hospital

Faisal A, Muslimin M, Widodo S YLA, et al. Journal of Pakistan Association of Dermatologists. 2021; 31 (1) : 78-84.
Download PDF
Publication

Caracterización clinicoepidemiológica de pacientes con lepra en un área de salud de Santiago de Cuba

Rojas NH, Gonzáles PF, Duany ZP. Medisan. 2021;
Download PDF
Publication

Morbimortalidade por hanseníase em idosos nos anos de 2010 a 2015 no estado de Goiás / Morbidity and mortality from leprosy in the elderly in the years 2010 to 2015 in the state of Goiás

Tavares MDPM, Tavares ADPM, Vilela MFDC, et al. Brazilian Journal of Health Review. Brazilian Journal of Health Review. 2021; 4 (2) : 4130-4134.
Download PDF
Publication

Diabetic Status of People Affected by Leprosy in Donorojo Leprosy Recovered Village: A Cross Sectional Study

Beladina N, Adisasmita A. Jurnal Epidemiologi Kesehatan Komunitas. 2021; 6 (1) : 191-199.
Download PDF
Publication

Pleomorphic and widespread lesions of phaeohyphomycosis in a leprosy patient on corticosteroid

Sirka CS, Sahu K, Hallur V, et al. Indian Dermatology Online Journal. 2021; 12 (2) : 319-323.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 281
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD